Benzinga’s Volume Movers

Genzyme Corp (NASDAQ: GENZ) shares gained 4.85% to $50.83 by 12:48 pm. The volume of GENZ shares traded was 383% higher than normal. GENZ’s Lumizyme has received FDA approval as a treatment for Pompe disease, a rare genetic disorder. OSI Systems Inc (NASDAQ: OSIS) shares climbed 4.31% to $25.63 by...